Home / Business / Pfizer to raise the cost of 41 drugs in January
Breaking News Home / Business / Pfizer to raise the cost of 41 drugs in January November 16, 2018 Business…
Prices of some of your medicines are about to go up.
Pfizer said on Friday that it will raise prices for 41 drugs or 10 percent of the product portfolio in January.
The giant of pharmacies indicates that the increase for most of the affected drugs would be 5 percent, but three products will increase by 3 percent and 9 percent will climb because of “the completion of two major development programs such as has led to the latest FDA approvals of two new medical uses that meet unchanged patient needs. “
Achieved by the US Today, a Pfizer spokesman would not mention the drugs that will be priced higher. The increases will come into force on January 15, 2019.
There is some history here. Pfizer had announced price increases at the beginning of July but bounced off, at least for a while after President Trump tweeted that “Pfizer & others will be ashamed that they have raised drug prices for no reason”. More: FDA: Head of Blood Pressure Medicine Reflects Increased Drug Safety Review
More: How much do your prescription drugs cost? Transparency in television ads is delayed
More: FDA recalls another blood pressure drug for possible cancer risk
Pfizer said it expects list prices to be “compensated by higher discounts and discounts paid to insurance companies and pharmaceutical benefit managers “and said that the net effect on the company’s sales growth in the US in 2019 is expected to be zero.
“We believe that the best way to manage affordable drugs is to reduce the growing costs of consumers facing high self-esteem and co-insurance, and ensure that patients get a discount on the pharmacy counter,” said Pfizer, chairman and Ian Read Group CEO in a statement.
“… Drug companies that raise their prices and counter them with higher discounts, benefit everyone, but the consumer who routinely pays off his pocket based on the list price,” wrote Caitlin Oakley, a healthcare specialist department in a statement to the USA today. “President Trump and Secretary Azar are still committed to reducing drug prices and reducing the cost of locks and continuing to take bold action to restructure this broken market.”
E-mail: [email protected], Follow US TODAY Personal Tech Columnist @edbaig on Twitter
Read or Share this story: https://www.usatoday.com/story/money/2018/11/16/ drug-price-hiking-p fizer-raise-cost-41 Drugs of January / 2029467002 /